Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001104659-24-098796
Filing Date
2024-09-11
Accepted
2024-09-11 08:45:02
Documents
9

Document Format Files

Seq Description Document Type Size
1 FORM S-3/A tm2423559d1_s3a.htm S-3/A 372875
2 EXHIBIT 5.1(A) tm2423559d1_ex5-1a.htm EX-5.1(A) 19611
3 EXHIBIT 5.1(B) tm2423559d1_ex5-1b.htm EX-5.1(B) 28097
4 EXHIBIT 23.1 tm2423559d1_ex23-1.htm EX-23.1 2376
5 GRAPHIC tm2423559d1_ex5-1aimg001.jpg GRAPHIC 13755
6 GRAPHIC tm2423559d1_ex5-1bimg001.jpg GRAPHIC 5632
7 GRAPHIC tm2423559d1_ex5-1bimg002.jpg GRAPHIC 5658
8 GRAPHIC tm2423995d1_s3aimg001.jpg GRAPHIC 2486
9 GRAPHIC tm2423995d1_s3aimg002.jpg GRAPHIC 32924
  Complete submission text file 0001104659-24-098796.txt   508405
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Theriva Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

EIN.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-279077 | Film No.: 241291493
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)